Search clinical trials for: Risperidone/Moxifloxacin

Total 1051 results

Rain Oncology Inc

Terminated

A Study of Milademetan Administration on Cardiac Repolarization in Healthy Subjects

Cardiac Repolarization

Australia
Tetraphase Pharmaceuticals, Inc.

Completed

A Thorough QT/QTc Study to Evaluate the Effects of an Intravenous Infusion of Eravacycline (TP-434) on Cardiac Repolarization

Normal Healthy Subjects
University of California, Los Angeles
National Institute of Mental Health (NIMH); Janssen Scientific Affairs, LLC

Completed

Psychosocial Therapy and Risperidone Treatment in Work Performance in Recent-Onset Schizophrenia

Schizophrenia

United States
Janssen-Cilag Ltd.

Completed

A Prospective Study of Risperdal (Risperidone) for the Treatment of Behavioral Disorder Following Psychological Therapy for Challenging Behavior in Learning Disabled Children

Child Behavior Disorders | Learning Disorders
Janssen, LP

Completed

A Long-term Safety Study for Long-acting Injectable Risperidone in Schizophrenia or Schizoaffective Disorder Patients.

Schizophrenia | Schizoaffective Disorder
Janssen Pharmaceutical K.K.

Completed

A Study of the Efficacy and Safety of Long-acting Injectable Risperidone and Risperidone Tablets in Patients With Schizophrenia

Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Efficacy and Safety of Risperidone Compared With Placebo in the Treatment of Psychotic Symptoms in Patients With Alzheimer's Disease

Mental Disorders | Dementia | Alzheimer Disease
Janssen Pharmaceutica N.V., Belgium

Completed

A Study of the Safety and Effectiveness of Risperidone Versus Placebo for the Treatment of Conduct Disorder in Children With Mild, Moderate, or Borderline Mental Retardation

Conduct Disorder | Oppositional Defiant Disorder | Disruptive Behavior Disorder
Janssen Korea, Ltd., Korea

Completed

A Study to Evaluate Symptomatic Remission in Schizophrenia With Long Acting Risperidone Microspheres

Schizophrenia
Novo Nordisk A/S

Completed

A Thorough QTc Evaluation of the Effect of Semaglutide on Cardiac Repolarisation in Healthy Subjects

Healthy | Diabetes

Germany
Genfit
Eurofins Optimed; PhinC Development; CardiaBase

Completed

Phase I Study to Evaluate the Effect of GFT505 on QT/QTc Interval in Healthy Volunteers

Healthy Volunteers

France
Dr. Reddy's Laboratories Limited

Completed

Bio-equivalency Study of Moxifloxacin Tablets, 400 mg Under Fasting Conditions

Healthy
Jazz Pharmaceuticals

Completed

Sativex Thorough QT/QTc Study

Effects of Sativex on ECG

Canada
Bausch Health Americas, Inc.

Completed

Prevention of Travelers' Diarrhea in Subjects Traveling Outside the U.S.

Diarrhea

United States
Bausch & Lomb Incorporated

Completed

A Study to Investigate the Safety and Efficacy of BOL-303224 in the Treatment of Bacterial Conjunctivitis

Acute Bacterial Conjunctivitis
Calico Life Sciences LLC
AbbVie

Recruiting

A Thorough QT Study of ABBV-CLS-7262 in Healthy Subjects

Healthy

United States
University Hospital, Ghent

Completed

Pharmacokinetic Evaluation of Moxifloxacin IV to Enteral Switch Therapy in Intensive Care Patients

Pneumonia

Belgium
Hoffmann-La Roche

Completed

A 2-Part Study to Evaluate the Safety of Supra-Therapeutic Doses of RO4602522 and to Investigate the Effect of RO4602522 on the QTc Interval

Healthy Volunteer

United States
Bayer

Completed

Bioavailability, Food Effect and Safety, Tolerability of a New Oral Suspension in Comparison to the Marketed Moxifloxacin Tablet in Healthy Adults

Healthy

Germany
Northwell Health

Completed

Prospective Cytochrome P450 Genotyping and Clinical Outcomes in Patients With Psychosis

Schizophrenia | Schizoaffective Disorder | Psychotic Disorder Not Otherwise Specified | Severe Bipolar Disorder With Psychotic Features

United States
GlaxoSmithKline

Completed

Schizophrenia Study In Adults

Schizophrenia

United States
Xijing Hospital
No. 102 Hospital of Chinese People's Liberation Army; The No.3 hospital of PLA and other collaborators

Unknown

Efficacy of Repetitive Transcranial Magnetic Stimulation in the Prevention of Relapse of Schizoaffective

Schizoaffective Disorder

China
Wyeth is now a wholly owned subsidiary of Pfizer
Solvay Pharmaceuticals

Terminated

Study Comparing Bifeprunox to Risperidone in Treatment of Outpatients With Schizophrenia With Weight as Primary Endpoint

Schizophrenia

United States
Johnson & Johnson Pharmaceutical Research & Development...
Janssen, LP

Completed

Study Comparing Adjunctive Risperidone Versus Placebo in Major Depressive Disorder That Is Not Responding to Standard Therapy

Major Depressive Disorder

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Effectiveness and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia

Psychotic Disorders | Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Bioequivalence Study Comparing 2 Formulations for 4 mg Risperidone Tablet.

Schizophrenia | Schizoaffective Disorders
Medical University of Vienna

Completed

Plasma and Abscess Fluid Pharmacokinetics of Cefpirome and Moxifloxacin After Single and Multiple Dose Administration

Cysts | Abscess

Austria
Federal University of São Paulo

Recruiting

Use Of Intracameral Moxifloxacin For Prophylaxis Of Open Globe Endophthalmitis

Endophthalmitis | Trauma, Corneal

Brazil
David Grant U.S. Air Force Medical Center

Terminated

Evaluation of Energy Drinks on Electrocardiographic, Vascular and Hematologic Parameters in Healthy Volunteers

Cardiovascular Diseases

United States
Facultad Nacional de Salud Publica
Universidad de Antioquia

Completed

Adjunctive Systemic Administration of Moxifloxacin in the Treatment of Aggressive Periodontitis

Aggressive Periodontitis

Colombia
University Hospital, Saarland
Bayer

Completed

Penetration of Moxifloxacin Into Liver Tissue of Patients Undergoing Liver Resection. (MOXI)

Side-effect of Antibiotic

Germany
University of Alabama at Birmingham
Janssen Pharmaceutica

Completed

Effective Measurement of Risperidone Treatment Outcome for Persons With Borderline Personality Disorder

Borderline Personality Disorder

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Efficacy and Safety of Risperidone in the Prevention of Relapse in Children and Adolescents With Conduct and Other Disruptive Behavior Disorders

Attention Deficit and Disruptive Behavior Disorders
Janssen Pharmaceutical K.K.

Terminated

A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's Disease

Dementia | Alzheimer's Disease
Janssen, LP

Completed

Evaluation of the Efficacy and Safety of Risperidone Injections Given Once a Month to Adults With Schizophrenia or Schizoaffective Disorder

Psychotic Disorders | Schizophrenia
Janssen-Ortho Inc., Canada

Completed

A Randomized, Open-label Trial of Long-acting Injectable Risperidone Versus Oral Antipsychotic Medication in Patients With Bipolar Disorder

Bipolar Disorder
Janssen Pharmaceutica N.V., Belgium

Completed

A Study of the Effectiveness and Safety of Risperidone Versus Placebo as add-on Therapy to Mood Stabilizers, in the Treatment of Manic Episodes Associated With Bipolar Disorder.

Bipolar Disorder | Manic Disorder
Stony Brook University

Completed

Liquid Risperidone in the Treatment of Acute Agitation in Psychiatrically Hospitalized Children

Agitation

United States
National Center for Research Resources (NCRR)
Yale University

Completed

Phase II Double Blind Placebo Controlled Trial of Risperidone in Tourette Syndrome

Tourette Syndrome
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study Comparing the Efficacy of Long-acting Injectable Risperidone and Olanzapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder

Psychotic Disorders | Schizophrenia
Janssen Pharmaceutical K.K.

Completed

A Pharmacokinetic and Safety Study of Risperidone Long Acting Injectable in Schizophrenic Patients

Schizophrenia
Janssen Pharmaceutica N.V., Belgium

Completed

Treatment With Risperidone Long Acting Injectable (RLAI) in an Early Phase of Psychosis

Psychotic Disorders | Schizophrenia | Schizoaffective Disorder
CTI BioPharma
Covance

Completed

To Evaluate the Cardiac Safety and PK Following a Single Oral Dose Administration of Pacritinib in Healthy Subjects

Healthy Subjects

United States
Connect Biopharma Australia Pty Ltd

Completed

A Study to Investigate the Effects of CBP-307 on the Heart Rate-corrected QT Interval (QTc) in Healthy Subjects

Autoimmune Diseases

Australia, United States
Actelion

Completed

Study of Selexipag and Its Metabolite ACT-333679 on Cardiac Repolarization in Healthy Male and Female Subjects

Pharmacokinetics | Tolerability | Safety | Cardiodynamics

United States
AstraZeneca

Completed

To Investigate the Effects of AZD1981 on the QT Interval

Asthma

United Kingdom
J. Uriach and Company

Completed

Evaluation of Possible Effects on the QT/ QTc Interval of Rupatadine in Healthy Volunteers

Human Experimentation (Human Volunteers)

Spain
TaiGen Biotechnology Co., Ltd.
QPS-Qualitix; R&G Pharma Studies Co.,Ltd.

Completed

Study to Evaluate the Efficacy and Safety of Intravenous Infusion With Nemonoxacin Malate Sodium Chloride

Pneumonia

Taiwan, China
Braeburn Pharmaceuticals

Completed

Safety and Tolerability of Risperidone Implants

Schizophrenia

United States
Braeburn Pharmaceuticals

Completed

Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant

Schizophrenia | Schizo-affective Disorder

United States

3

Subscribe